Skip to content

Multicenter RCT Study of Electroacupuncture in the Treatment of Premature Ovarian Insufficiency

Multicenter RCT Study of Electroacupuncture in the Treatment of Premature Ovarian Insufficiency

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002571
Enrollment
Unknown
Registered
2025-12-27
Start date
2026-01-12
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ovarian Insufficiency

Interventions

Observation group:Electroacupuncture

Sponsors

The First Hospital of Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1) After hormone or B ultrasound diagnosis, in line with the above diagnostic criteria of Chinese and Western medicine ; 2) Accept acupuncture treatment and have a clear prescription of acupuncture ; 3) Patients who voluntarily participated in the clinical trial and cooperated with the examination and treatment, and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients who did not meet the above diagnostic criteria or inclusion criteria ; 2) Patients with heart, lung, liver, kidney, rheumatic immune, endocrine and other serious primary diseases or heart, lung, liver, kidney, brain failure and malignant tumors or precancerous lesions affected by sex hormones ; 3) Patients with ovarian dysfunction caused by ovarian, uterine and other related operations ; 4) Patients with congenital reproductive organ dysplasia or combined with polycystic ovary syndrome, hyperprolactinemia, hyperandrogenism, hypothyroidism, chronic adrenocortical dysfunction and other endocrine diseases affecting ovulation ; 5) Women in pregnancy or lactation ; 6) Those who were allergic to the drugs used in this study or who were suffering from other diseases or were receiving treatment that may have an impact on the indicators of this study ; 7) Patients with fainting or continuous damage of skin tissue at the acupuncture site, infection, coagulation dysfunction and skin allergy ; 8) Those who cannot cooperate with mental disorders, or cannot tolerate the blood or ultrasound detection and acupuncture treatment in the course of this study.

Design outcomes

Primary

MeasureTime frame
Serum basic sex hormone levels;Anti-mullerian hormone;

Secondary

MeasureTime frame
Chinese medicine syndrome scores;CD4+ T cell level;CD8+ T cell level;AFC and Hemodynamics;Kupperman index;Changes in intestinal flora content;Olink targeted proteomics;Transcriptomics;

Countries

China

Contacts

Public ContactZhang Wei

The First Hospital of Hunan University of Chinese Medicine

zhangwei@hnucm.edu.cn+86 135 4863 9198

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026